HeartMate 3 heart pump reduces device clotting in heart failure patients
At two years of follow-up, severely ill patients with advanced heart failure who received HeartMate 3, a new heart pump fully implantable within the chest experienced no malfunctions requiring replacement or removal of the device for blood clotting, according to research presented March 11, 2018 at the recent American College of Cardiology’s 67th Annual Scientific Session in Orlando, Florida. HeartMate 3, a mechanical heart pump fully implantable within the chest, is the first to use f
To continue reading this article
Continue reading your article with a eMediNexus account.